.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Propofol is the most widely used intravenous anesthetic agent in modern clinical practice. However, doctors often face challenges due to the significant interindividual variability in how patients respond to the drug. To address these variations, researchers have developed a high-throughput method for plasma propofol quantification. This advancement is essential because current population-based dosing algorithms often fail to provide the precision required for every surgical patient.
Specifically, the study details a new liquid chromatography-tandem mass spectrometry (LC-MS/MS) assay. This method utilizes protein precipitation to achieve a rapid total run-time of only 5.5 minutes. Furthermore, the assay demonstrates remarkable accuracy and stability across a broad quantification range of 25 to 5000 ng/mL. Consequently, this reliable tool allows for the efficient processing of large-scale samples in clinical pharmacokinetic studies. Additionally, the method remains robust even under various storage and handling conditions, ensuring data integrity.
The primary utility of this bioanalytical method lies in its ability to inform pharmacokinetic-pharmacodynamic modeling. By providing accurate plasma propofol quantification data, the assay helps refine Target-Controlled Infusion (TCI) algorithms. As a result, anesthesiologists can develop more individualized dosing strategies for patients undergoing major noncardiac surgery. In conclusion, this fit-for-purpose method significantly supports the transition toward more personalized and safer anesthetic management.
It allows researchers to precisely measure drug concentrations, which is vital for creating accurate dosing models that account for individual patient differences.
The assay is highly efficient with a 5.5-minute run-time and offers high extraction recovery. It also remains stable under various conditions like freeze-thaw cycles and long-term storage.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice. Always seek the advice of a qualified healthcare provider with any questions regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Researchers developed a robust LC-MS/MS assay for plasma propofol quantification to improve target-controlled infusion algorithms and individualized dosing....
last month
The Delhi High Court has issued a notice to the Centre and FSSAI regarding a plea for an India-specific scientific evaluation of non-sugar sweeteners. The petition highlights concerns over metabolic risks, front-of-pack labeling, and misleading health claims on artificial substitutes.
Today
An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
4 days back
A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
5 days back
Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
4 days back
A UK Biobank study of 471,540 participants reveals that metabolic syndrome increases incident gastric cancer risk by 36% (HR=1.36). A positive trend was observed with accumulating metabolic components, with waist circumference showing the strongest association, highlighting modifiable risk targets.
5 days back
